Search clinical trials for: allergic dermatitis

Total 6130 results

University of Helsinki

Completed

Bronchial Hyperreactivity in Atopic Dermatitis Patients - a 10 Year Follow-up

Atopic Dermatitis

Finland
Hom, Milton M., OD, FAAO
Bausch & Lomb Incorporated

Unknown

Use of BEPREVE (Bepotastine Besilate Ophthalmic Solution) 1.5% for Allergic Conjunctivitis and Contact Lenses

Allergic Conjunctivitis
Novartis
Genentech, Inc.; Tanox

Completed

A Study of Efficacy of New Doses of Xolair to Protect From Allergen Challenge in Groups of Asthma Patients Defined by IgE Levels

Asthma

Germany, Netherlands, South Africa
Palau Pharma S.A.

Completed

Proof of Activity Study of UR-63325 in Allergic Rhinitis Induced by Nasal Challenge

Seasonal Allergic Rhinitis

Germany
Frankel, Amylynne, M.D.
Onset Therapeutics, Inc

Completed

Bilateral Comparison Study of Elidel 1% and Hylatopic Plus Emollient Foam for the Treatment of Subjects With Atopic Dermatitis

Eczema | Atopic Dermatitis

United States
Grünenthal Colombiana S.A.

Completed

Cost-effectiveness Study of Beclomethasone Versus Ciclesonide as Controller Medications in Pediatric Asthma

Asthma

Colombia
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

A Study to Evaluate the Impact on Skin (Injection Site) Reactions of Taking an Antihistamine (Zyrtec®) or Placebo Prior to Daily Injections of Copaxone®.

Multiple Sclerosis
Federico II University
University of Campania "Luigi Vanvitelli"

Completed

Effectiveness Of Therapy With A Thermal Water Nasal Aerosol In Children With Seasonal Allergic Rhinitis

Allergic Rhinitis (Disorder)

Italy
University of Dundee
Merck Sharp & Dohme LLC

Completed

Add-on Salmeterol Versus Montelukast in Arg/Arg-16 Asthmatics

Asthma

United Kingdom
Novartis Pharmaceuticals

Terminated

Safety and Efficacy of Pimecrolimus Cream 1% in Atopic Disease Modification

Atopic Dermatitis

United States
St. Justine's Hospital

Unknown

Cyproheptadine as an Appetite Stimulant

Failure to Thrive

Canada
Rush University Medical Center
Astellas Pharma US, Inc.

Completed

Study to Evaluate the Safety and Efficacy of Alefacept (Amevive) in Subjects With Moderate to Severe Atopic Dermatitis

Atopic Dermatitis

United States
University of California, Los Angeles
Novartis; Genentech, Inc.

Terminated

Non-invasive Measures of Effects of Xolair in Asthma

Asthma

United States
Research in Real-Life Ltd
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Real-life Effectiveness and Cost-effectiveness of Qvar Versus FP and BDP in the Management of COPD (QvarCOPD)

Chronic Obstructive Pulmonary Disease

United Kingdom
Pfizer

Completed

Study To Assess The Effect Of Gabapentin, Diphenhydramine And Morphine On Cold Pain In Healthy Male Volunteers

Healthy

Belgium
Hadassah Medical Organization

Unknown

Climatotherapy At The Dead Sea For Atopic Dermatitis

Atopic Dermatitis

Israel
BioTech Tools S.A.

Completed

Clinical Safety and Tolerability Study of gpASIT+TM and gpASIT+TM/Immunoregulating Adjuvant to Treat Seasonal Grass Pollen Rhinoconjunctivitis

Seasonal Allergic Rhinoconjunctivitis

Belgium
University of Helsinki
Solvay Pharmaceuticals

Completed

Duodenal Levodopa Infusion, Quality of Life and Autonomic Nervous System in Parkinson's Disease

Parkinson's Disease

Finland
University of Zurich

Completed

Study of Specific Allergen Immunotherapy in Grass Pollen Allergic Subjects by Epicutaneous Allergen Administration

Allergies

Switzerland
Lytix Biopharma AS

Completed

A Study to Evaluate Safety, Tolerability and Efficacy of Lytixar™ (LTX-109) on Uncomplicated, Gram-positive, Skin Infection

Atopic Dermatitis | Gram-positive, Skin Infections | Mild Eczema/Dermatoses

Hungary
Johann Wolfgang Goethe University Hospital

Completed

Evaluation of Bronchial Inflammation in Allergic Bronchopulmonary Aspergillosis (ABPA) (ABPA)

Cystic Fibrosis,

Germany
Beijing Tongren Hospital

Completed

Interaction Effect of Asthma and Aeroallergen Category on the Psychological Status in Allergic Rhinitis Patients

Respiratory Tract Diseases | Hypersensitivity | Allergic Rhinitis | Psychologic Factors in Physical Conditions Classified Elsewhere
MDCPharma Produtos Farmaceuticos LTDA

Unknown

Study to Evaluate the Efficacy and Tolerability of Apevinat BC Compared to Vitamin Complex

Anorexia | Lack of Appetite

Brazil
IRCCS Policlinico S. Matteo

Completed

Omalizumab in Interstitial Cystitis/Bladder Pain Syndrome (IComaliz)

Interstitial Cystitis | Painful Bladder Syndrome

Italy
Laval University

Terminated

Early Antiinflammatory Treatment of Asthma (EATA)

Asthma | Bronchial Hyperreactivity

Canada
Beijing Tongren Hospital

Completed

Distinct Response of CD4+CD25+Foxp3+ and IL-10-secreting Type I T Regulatory Cells to Cluster Specific Immunotherapy in Allergic Rhinitis Children

Allergic Rhinitis | Effects of Immunotherapy

China
Ramathibodi Hospital

Completed

Randomized Controlled Trial of Subconjunctival Bevacizumab Injection in Impending Recurrent Pterygium

Pterygium of the Conjunctiva and Cornea

Thailand
University of Zurich

Completed

Study of Specific Allergen Immunotherapy in Grass Pollen Allergic Subjects With Epicutanoeus Allergen Administration (ZU-SkinSIT-003)

Allergic Rhinoconjunctivitis

Switzerland
Azidus Brasil

Unknown

Comparative Efficacy of the Suppository Versus Guaiacol Suppository Versus Guaifenesin Syrup in Pediatric Patients With Cough Due the Infectious Origin

Cough

Brazil
AstraZeneca

Completed

Assess the Efficacy and Safety of Rhinocort Aqua

Allergic Rhinitis
AstraZeneca

Completed

Comparison of the Efficacy/Safety of Symbicort® Turbuhaler®,Seretide™ Diskus™ 50/500 µg & Terbutaline Turbuhaler® 0.4 mg

Asthma

Brazil, France, South Africa, Spain, Vietnam, Germany, Philippines, Malaysia, China, Canada, Argentina, Australia, Mexico, Thailand, Indonesia, Singapore, India
AstraZeneca

Completed

Rhinocort Aqua Versus Placebo and Fluticasone Propionate

Seasonal Allergic Rhinitis
AstraZeneca

Completed

Airway Clearance Study

Chronic Obstructive Pulmonary Disease

United Kingdom, Sweden
AstraZeneca

Completed

Symbicort Onset of Action 2

Asthma
AstraZeneca

Completed

SMILDA - Symbicort®Turbuhaler® Allergan Challenge Study in Allergic Patients With Mild Asthma

Asthma

Sweden
AstraZeneca

Completed

New Nasal Applicator / New Formulation - User Study

Seasonal Allergic Rhinitis
King's College London

Unknown

Omalizumab in Non-atopic Asthma

Bronchial Asthma

United Kingdom
Juravinski Cancer Centre Foundation

Completed

Magic Mouthwash Plus Sucralfate Versus Benzydamine Hydrochloride for the Treatment of Radiation-induced Mucositis

Head and Neck Cancer | Mucositis

Canada
Sanofi

Completed

Single-Center, Double-Blind, Randomized , Parallel Study Comparing Onset of Action, Efficacy & Safety of a Single-Dose of Fexofenadine HCl 180 mg vs Montelukast Na 10 mg & Placebo in Treating Seasonal Allergic Rhinitis Subjects in an Allergen Exposure Unit

Seasonal Allergic Rhinitis

United States
Sanofi

Completed

A Single-Center, Randomized, Double-Blind, Placebo-Controlled, Two-Way Crossover Study Designed to Evaluate the Efficacy of Fexofenadine HCl 180 mg for Preventing and Controlling Cat Allergy Symptoms

Cat Induced Allergic Rhinitis
Sanofi

Completed

Comparative Study Evaluating the Effects of Fexofenadine HCI 180 mg With Orange Juice Versus Placebo With Orange Juice in a Skin Wheal and Flare Challenge Model.

Allergy

United States
Sanofi

Completed

An Efficacy and Safety Evaluation of Nasacort AQ in Children Ages 2-5 Years With Perennial Allergic Rhinitis

Rhinitis, Allergic, Perennial

United States
Sanofi

Completed

Fexofenadine HCl 180 mg, Desloratadine 5 mg and Placebo in Suppression of Wheal and Flare Induced by Histamine

Allergic Rhinitis

United States
Sanofi

Completed

Fexofenadine HCl 180 mg, Montelukast Sodium 10 mg and Placebo in Suppression of Wheal and Flare Induced by Seasonal Allergen

Allergic Rhinitis

United States
Sanofi

Completed

Fexofenadine (Allegra®) in Healthy Adults Who Have Been Identified as Slow Metabolizers for Desloratadine

Allergic Rhinitis

United States
Sanofi

Completed

Single Center, Randomized, Double-Blind,Crossover Study Comparing Effects Of Single-Dose Fexofenadine HCl 180 mg, Cetirizine 10 mg, and Placebo on Cognitive Performance in Naval Flight Personnel

Seasonal Allergic Rhinitis

United States
Nuon Therapeutics, Inc.

Completed

Tranilast Plus Allopurinol in Patients With Moderate to Severe Gout (TAnGO)

Hyperuricemia | Moderate to Severe Gout

United States
Nuon Therapeutics, Inc.

Completed

Study of Tranilast Alone or in Combination With Febuxostat in Patients With Hyperuricemia

Hyperuricemia | Gout

United States
Nuon Therapeutics, Inc.

Completed

Study of Tranilast Alone or in Combination With Allopurinol in Subjects With Hyperuricemia

Hyperuricemia | Gout

United States
Nuon Therapeutics, Inc.

Completed

Safety and Efficacy Study of Tranilast in Patients With Active Rheumatoid Arthritis (RA)

Active Rheumatoid Arthritis

United Kingdom, United States, Argentina, Bulgaria, Serbia, Germany, Mexico, Czech Republic

3

Subscribe